CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
0.425 % w/w phytate,1150ppm F +5 moredrug
Likely dose
0.85 % w/w phytate,0.3%ZnCl2 0.5% sodium citrate, 1150ppm Ffrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02751320
NCT02751320N/ACompleted

Clinical Efficacy of Three Experimental Toothpastes Using an in Situ Caries Model

GlaxoSmithKline·interventional·Posted Apr 26, 2016·Updated Oct 13, 2017

In Brief

A clinical study evaluating 0.425 % w/w phytate,1150ppm F, 0.85 % w/w phytate,1150ppm F, and 4 other interventions for Dental Caries. Completed, enrolled 58 participants across 1 site.

Detailed Summary

This will be a single-centre, randomized, blinded, placebo-controlled, 6-treatment, 4-period crossover, incomplete block design, in situ caries study in healthy adults who wear a removable bilateral mandibular partial denture. The denture will be modified to accommodate 4 gauze-covered specimens of human dental enamel (4x3mm) that have been previously demineralized in vitro to form either S or low-R lesions (2 specimens of each lesion type will be used with each participant). After 14 days of twice daily product use off-site, the 2 S lesion specimens will be removed at the study site, with the remaining 2 low-R lesion specimens removed at the study site after a further 14 days of product use. To determine the remineralization ability of the treatments, all specimens will be analyzed by transverse microradiography (TMR) and enamel fluoride uptake (EFU), with the S lesions additionally analyzed by surface micro hardness (SMH) and the low-R lesions additionally analyzed by quantitative light fluorescence (QLF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Caries
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 26, 2016
Enrollment StartFeb 1, 2016
Primary CompletionJul 1, 2016
Study CompletionAug 11, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.2 years ago

Interventions

0.425 % w/w phytate,1150ppm Fdrug

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

0.85 % w/w phytate,1150ppm Fdrug

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

0.85 % w/w phytate,0.3%ZnCl2 0.5% sodium citrate, 1150ppm Fdrug

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

0 ppm Fother

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

1150ppm Fdrug

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

0.3%ZnCl2, 0.5% sodium citrate, 1150ppm Fdrug

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.